SVB Leerink analyst Andrew Berens maintains Blueprint Medicines (NASDAQ:BPMC) with a Market Perform and lowers the price target from $60 to $56.
Navigator Holdings Ltd. Announces Additional Vessel Acquisitions Under 60/40 Joint Venture With Greater Bay Gas
Navigator Holdings Ltd. ("Navigator" or "Company") (NYSE:NVGS), the owner and operator of the world's largest fleet of handysize liquefied gas carriers, is pleased to announce the third and fourth